Pharma Journalist -

SanegeneBio has entered a global licensing agreement with Genentech, part of the Roche Group, granting the pharmaceutical company exclusive worldwide rights to develop and commercialize…
Read More...

Immix Biopharma, Inc., a clinical-stage biotechnology company focused on developing therapies for difficult-to-treat diseases, has received a major regulatory boost after the U.S. Food…
Read More...

WuXi Biologics and Sinorda Biomedicine have entered into a strategic collaboration to advance the development and manufacturing of SND006, a novel bispecific antibody being developed…
Read More...

Recordati has entered into a global collaboration and licensing agreement with Moderna to develop and commercialize mRNA-3927, an investigational mRNA-based therapy for the treatment of…
Read More...

IQVIA, a global provider of clinical research services, healthcare intelligence, and commercial insights, has entered into a strategic long-term collaboration with Boehringer Ingelheim…
Read More...

The Lupus Research Alliance has welcomed the U.S. Food and Drug Administration’s decision to grant Breakthrough Therapy designation to litifilimab (BIIB059), an investigational…
Read More...

Sensorion, a clinical-stage biotechnology company focused on developing novel treatments to restore, treat, and prevent hearing loss, has announced a €60 million capital raise to…
Read More...

AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic collaboration with CSPC Pharmaceuticals, targeting the development of multiple…
Read More...

AstraZeneca has announced a landmark $15 billion investment in China through 2030, significantly expanding its research, development, and manufacturing capabilities as part of its…
Read More...

Repertoire® Immune Medicines, a biotechnology company focused on programmable T cell–targeted immune medicines, has entered into a major strategic collaboration with Eli Lilly and…
Read More...